Viveve Medical designs, develops, manufactures and markets a platform medical technology, which the company refers to as Cryogen-cooled Monopolar RadioFrequency (CMRF). The company's CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, that collectively, the company refers to as the Viveve System?. The Viveve System is being marketed outside of the U.S. for the non-invasive treatment of several post-partum conditions including vaginal introital laxity, for improved sexual function, and for vaginal rejuvenation, that the company refers to as the Geneveve? treatment. The Viveve System uses a patented method of delivering monopolar radiofrequency energy for treating tissue.